BackImmuPharma plc Overview

ImmuPharma plc Accounts Payable

ImmuPharma plc's accounts payable is $1.3M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.28M
↑ 2.61% YoYΔ $32465.00 vs prior year quarter

Peer trimmed avg / median

Loading

ImmuPharma plc Accounts Payable History

Loading

ImmuPharma plc vs. peers: Accounts Payable Comparison

Loading

ImmuPharma plc Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ImmuPharma plc (IMMPF) FAQ

ImmuPharma plc (IMMPF) currently reports a accounts payable of $1.3M as of June 2026. That compares with $1.2M in the prior-year period — up 2.6% year over year. Use the charts on this page to explore ImmuPharma plc's accounts payable history and peer comparisons.

ImmuPharma plc's accounts payable increased from $1.2M to $1.3M — a 2.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ImmuPharma plc reported $1.3M in accounts payable as of June 2026. That compares with $1.2M in the prior-year period — up 2.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ImmuPharma plc, and consider following IMMPF for alerts when major investors trade the stock.

ImmuPharma plc is classified in the Healthcare sector. On accounts payable, it currently shows $1.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMMPF with unrelated industries.

Questions & Answers